Adiponectin and Cognitive Decline

Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis

(2019) Ruth Peters et al.   BMJ Open

Effects of running on adiponectin, insulin and cytokines in cerebrospinal fluid in healthy young individuals

(2019) M. Schön et al.   Scientific Reports

Neurovascular and Cognitive Dysfunction in Hypertension

(2019) Costantino Iadecola et al.   CIRCULATION RESEARCH

Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of microglia via AdipoR1-AMPK-NF-κB signaling pathway

(2019) Min Jian et al.   Journal of Neuroinflammation

Vascular Cognitive Impairment and Dementia

(2019) Costantino Iadecola et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature

(2019) Delia Gagliardi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Re-thinking the Etiological Framework of Neurodegeneration

(2019) Ximena Castillo et al.   Frontiers in Neuroscience

Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task

(2019) Tommaso Cassano et al.   Frontiers in Pharmacology

β-Amyloid Peptide: the Cell Compartment Multi-faceted Interaction in Alzheimer’s Disease

(2019) Pasquale Picone et al.   NEUROTOXICITY RESEARCH

Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer’s Disease

(2018) Christopher R. Beam et al.   JOURNAL OF ALZHEIMERS DISEASE

Cerebrovascular and Alzheimer disease: fellow travelers or partners in crime?

(2018) Antonia Nucera et al.   JOURNAL OF NEUROCHEMISTRY

Evolving targets for the treatment of atherosclerosis

(2018) Ankita Solanki et al.   PHARMACOLOGY & THERAPEUTICS

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?

(2018) Cyril Laurent et al.   Biomedical Journal

Association between insulin resistance and the development of cardiovascular disease

(2018) Valeska Ormazabal et al.   Cardiovascular Diabetology

Altered Serum Levels of Adipokines and Insulin in Probable Alzheimer's Disease

(2018) Vineet Kumar Khemka et al.   JOURNAL OF ALZHEIMERS DISEASE

Metabolic Syndrome and Longitudinal Changes in Cognitive Function: A Systematic Review and Meta-Analysis

(2018) Mario Siervo et al.   JOURNAL OF ALZHEIMERS DISEASE

Modulation of Glucose Metabolism in Hippocampal Neurons by Adiponectin and Resistin

(2018) Pedro Cisternas et al.   MOLECULAR NEUROBIOLOGY

Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies

(2018) John A. Batsis et al.   Nature Reviews Endocrinology

A Natural Dietary Supplement with a Combination of Nutrients Prevents Neurodegeneration Induced by a High Fat Diet in Mice

(2018) Domenico Nuzzo et al.   Nutrients

Role of Adiponectin in Central Nervous System Disorders

(2018) Jenna Bloemer et al.   NEURAL PLASTICITY

Blood-Brain Barrier: From Physiology to Disease and Back

(2018) Melanie D. Sweeney et al.   PHYSIOLOGICAL REVIEWS

Potential Neuroprotective Effects of Adiponectin in Alzheimer’s Disease

(2017) Roy Ng et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction

(2017) et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Inflammation, metaflammation and immunometabolic disorders

(2017) Gökhan S. Hotamisligil   NATURE

Adiponectin attenuates high glucose-induced apoptosis through the AMPK/p38 MAPK signaling pathway in NRK-52E cells

(2017) Yuanyuan Wang et al.   PLoS One

Serum adiponectin levels are associated with worse cognitive function in postmenopausal women

(2017) Pasquale De Franciscis et al.   PLoS One

Globular Adiponectin Limits Microglia Pro-Inflammatory Phenotype through an AdipoR1/NF-κB Signaling Pathway

(2017) Sarah Nicolas et al.   Frontiers in Cellular Neuroscience

Alzheimer’s disease prevention: from risk factors to early intervention

(2017) Marta Crous-Bou et al.   Alzheimers Research & Therapy

Endothelial dysfunction and vascular disease - a 30th anniversary update

(2016) P. M. Vanhoutte et al.   Acta Physiologica

The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia

(2016) Lora Dukic et al.   CLINICAL BIOCHEMISTRY

Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis

(2016) Chenxiao Liu et al.   CYTOKINE

Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer’s Disease

(2016) Masaaki Waragai et al.   JOURNAL OF ALZHEIMERS DISEASE

Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging

(2016) Alexandra M.V. Wennberg et al.   JOURNAL OF ALZHEIMERS DISEASE

Alzheimer’s like brain changes correlate with low adiponectin plasma levels in type 2 diabetic patients

(2016) Natalia García-Casares et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Chronic adiponectin deficiency leads to Alzheimer’s disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice

(2016) Roy Chun-Laam Ng et al.   Molecular Neurodegeneration

Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype

(2016) Jamaica R. Rettberg et al.   NEUROBIOLOGY OF AGING

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention

(2016) Rachael A. Lawson et al.   PARKINSONISM & RELATED DISORDERS

PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome

(2016) Hong Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Adiponectin signaling and function in insulin target tissues

(2016) Hong Ruan et al.   Journal of Molecular Cell Biology

Progression of Metabolic Syndrome Severity During the Menopausal Transition

(2016) Matthew J. Gurka et al.   Journal of the American Heart Association

The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease

(2016) Giuseppe Tosto et al.   JAMA Neurology

Advances in Nanotechnology for the Treatment of Osteoporosis

(2016) Mikayla Barry et al.   Current Osteoporosis Reports

AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo

(2016) Manon Domise et al.   Scientific Reports

Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib

(2015) Naoki Ishijima et al.   CANCER SCIENCE

Serum high-molecular-weight adiponectin level and incident dementia in patients with vascular risk factors

(2015) K. Kitagawa et al.   EUROPEAN JOURNAL OF NEUROLOGY

Trajectory of Cognitive Decline After Incident Stroke

(2015) Deborah A. Levine et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Adiponectin, leptin and IL-1 β in elderly diabetic patients with mild cognitive impairment

(2015) Malgorzata Gorska-Ciebiada et al.   METABOLIC BRAIN DISEASE

Obesity, adipokines and neuroinflammation

(2015) Argel Aguilar-Valles et al.   NEUROPHARMACOLOGY

Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults

(2015) Paula T. Trzepacz et al.   BMC Geriatrics

Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?

(2014) Enrique Z Fisman et al.   Cardiovascular Diabetology

Mild Cognitive Impairment: A Concept and Diagnostic Entity in Need of Input from Neuropsychology

(2014) Mark W. Bondi et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Mild Cognitive Impairment and Mild Dementia: A Clinical Perspective

(2014) David S. Knopman et al.   MAYO CLINIC PROCEEDINGS

Role of adiponectin system in insulin resistance

(2014) Chiara Caselli   MOLECULAR GENETICS AND METABOLISM

TNF and MAP kinase signalling pathways

(2014) Guadalupe Sabio et al.   SEMINARS IN IMMUNOLOGY

Role of anti-inflammatory adipokines in obesity-related diseases

(2014) Koji Ohashi et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Association between Risk Factors for Vascular Dementia and Adiponectin

(2014) Juhyun Song et al.   Biomed Research International

New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases

(2014) Ersilia Nigro et al.   Biomed Research International

Serum total adiponectin level and the risk of cardiovascular disease in general population: A meta-analysis of 17 prospective studies

(2013) Guang Hao et al.   ATHEROSCLEROSIS

Normal Cognitive Aging

(2013) Caroline N. Harada et al.   CLINICS IN GERIATRIC MEDICINE

Effects of Gonadal Hormones on Cognitive Behaviour in Elderly Men and Women

(2013) E. Hogervorst   JOURNAL OF NEUROENDOCRINOLOGY

Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition

(2013) Brittany L. Adler et al.   NEUROBIOLOGY OF AGING

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal

(2013) R. O. Roberts et al.   NEUROLOGY

Adiponectin signaling in the liver

(2013) Terry P. Combs et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Anti-inflammatory and anti-atherogenic properties of adiponectin

(2012) Koji Ohashi et al.   BIOCHIMIE

Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias

(2012) M. Yarchoan et al.   BRAIN

Evidence of a Causal Relationship Between Adiponectin Levels and Insulin Sensitivity: A Mendelian Randomization Study

(2012) H. Gao et al.   DIABETES

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

(2012) Konrad Talbot et al.   JOURNAL OF CLINICAL INVESTIGATION

Association between hippocampal volume and serum adiponectin in patients with type 2 diabetes mellitus

(2012) Takayuki Masaki et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease

(2012) Antonio L. Teixeira et al.   NEUROMOLECULAR MEDICINE

Adiponectin is Protective against Oxidative Stress Induced Cytotoxicity in Amyloid-Beta Neurotoxicity

(2012) Koon-Ho Chan et al.   PLoS One

Adipocytokines and the risk of ischemic stroke: The PRIME Study

(2011) Christof Prugger et al.   ANNALS OF NEUROLOGY

The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease

(2011) P. L. McClean et al.   JOURNAL OF NEUROSCIENCE

Adipokines and stroke: A review of the literature

(2011) C. Savopoulos et al.   MATURITAS

The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia

(2010) Costantino Iadecola   ACTA NEUROPATHOLOGICA

Ghrelin, leptin, adiponectin, and insulin levels and concurrent and future weight change in overweight, postmenopausal women

(2010) Amy C. Soni et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Endogenous oestrogens predict 4-year decline in verbal fluency in postmenopausal women: the Rancho Bernardo Study

(2009) Gail A. Laughlin et al.   CLINICAL ENDOCRINOLOGY

Adiponectin: from obesity to cardiovascular disease

(2009) C. Antoniades et al.   Obesity Reviews

Review: Blood pressure and dementia — a comprehensive review

(2009) Sean P. Kennelly et al.   Therapeutic Advances in Neurological Disorders

Menopause and the Metabolic SyndromeThe Study of Women's Health Across the Nation

(2008) Imke Janssen   ARCHIVES OF INTERNAL MEDICINE

Adipocytokines and risk of stroke in older people: a nested case–control study

(2008) David J Stott et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Complete Rescue of Cerebrovascular Function in Aged Alzheimer's Disease Transgenic Mice by Antioxidants and Pioglitazone, a Peroxisome Proliferator-Activated Receptor   Agonist

(2008) N. Nicolakakis et al.   JOURNAL OF NEUROSCIENCE

Change in adipocytokines and ghrelin with menopause

(2008) MaryFran R. Sowers et al.   MATURITAS

Metabolic syndrome after menopause and the role of hormones

(2008) Rogerio A. Lobo   MATURITAS

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

(2008) Aileen M. Moloney et al.   NEUROBIOLOGY OF AGING

The role of executive function and attention in gait

(2007) Galit Yogev-Seligmann et al.   MOVEMENT DISORDERS